[ET Net News Agency, 27 April 2021] Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
(02196) said for the three months ended 31 March 2021, net profit attributable to
shareholders of the listed company was RMB847.19 million, a year-on-year increase of
46.78%. Basic earnings per share were RMB0.33.
Operating revenue was RMB8.06 billion, a year-on-year increase of 37%. (RC)